These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2107 related articles for article (PubMed ID: 31068700)

  • 21. Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell lines.
    Liu W; Li L; Li W
    Int J Cancer; 2014 Dec; 135(12):2795-803. PubMed ID: 24771271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.
    Reinhold WC; Varma S; Sunshine M; Elloumi F; Ofori-Atta K; Lee S; Trepel JB; Meltzer PS; Doroshow JH; Pommier Y
    Cancer Res; 2019 Jul; 79(13):3514-3524. PubMed ID: 31113817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the consistency of large-scale pharmacogenomic studies.
    Rahman R; Dhruba SR; Matlock K; De-Niz C; Ghosh S; Pal R
    Brief Bioinform; 2019 Sep; 20(5):1734-1753. PubMed ID: 31846027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Trends in Drug Sensitivity Prediction.
    Cortes-Ciriano I; Mervin LH; Bender A
    Curr Pharm Des; 2016; 22(46):6918-6927. PubMed ID: 27784247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
    Aquino-Jarquin G
    Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The landscape of cancer cell line metabolism.
    Li H; Ning S; Ghandi M; Kryukov GV; Gopal S; Deik A; Souza A; Pierce K; Keskula P; Hernandez D; Ann J; Shkoza D; Apfel V; Zou Y; Vazquez F; Barretina J; Pagliarini RA; Galli GG; Root DE; Hahn WC; Tsherniak A; Giannakis M; Schreiber SL; Clish CB; Garraway LA; Sellers WR
    Nat Med; 2019 May; 25(5):850-860. PubMed ID: 31068703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers.
    Ye J; Zou M; Li P; Liu H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818805997. PubMed ID: 30444190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.
    McDonald ER; de Weck A; Schlabach MR; Billy E; Mavrakis KJ; Hoffman GR; Belur D; Castelletti D; Frias E; Gampa K; Golji J; Kao I; Li L; Megel P; Perkins TA; Ramadan N; Ruddy DA; Silver SJ; Sovath S; Stump M; Weber O; Widmer R; Yu J; Yu K; Yue Y; Abramowski D; Ackley E; Barrett R; Berger J; Bernard JL; Billig R; Brachmann SM; Buxton F; Caothien R; Caushi JX; Chung FS; Cortés-Cros M; deBeaumont RS; Delaunay C; Desplat A; Duong W; Dwoske DA; Eldridge RS; Farsidjani A; Feng F; Feng J; Flemming D; Forrester W; Galli GG; Gao Z; Gauter F; Gibaja V; Haas K; Hattenberger M; Hood T; Hurov KE; Jagani Z; Jenal M; Johnson JA; Jones MD; Kapoor A; Korn J; Liu J; Liu Q; Liu S; Liu Y; Loo AT; Macchi KJ; Martin T; McAllister G; Meyer A; Mollé S; Pagliarini RA; Phadke T; Repko B; Schouwey T; Shanahan F; Shen Q; Stamm C; Stephan C; Stucke VM; Tiedt R; Varadarajan M; Venkatesan K; Vitari AC; Wallroth M; Weiler J; Zhang J; Mickanin C; Myer VE; Porter JA; Lai A; Bitter H; Lees E; Keen N; Kauffmann A; Stegmeier F; Hofmann F; Schmelzle T; Sellers WR
    Cell; 2017 Jul; 170(3):577-592.e10. PubMed ID: 28753431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer.
    Goodspeed A; Jean A; Costello JC
    Eur Urol; 2019 Feb; 75(2):242-250. PubMed ID: 30414698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies.
    Pozdeyev N; Yoo M; Mackie R; Schweppe RE; Tan AC; Haugen BR
    Oncotarget; 2016 Aug; 7(32):51619-51625. PubMed ID: 27322211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug Resistance in Cancer Therapy and the Role of Epigenetics.
    Asano T
    J Nippon Med Sch; 2020 Dec; 87(5):244-251. PubMed ID: 32475898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of DNA, RNA and histone methylation in ageing and cancer.
    Michalak EM; Burr ML; Bannister AJ; Dawson MA
    Nat Rev Mol Cell Biol; 2019 Oct; 20(10):573-589. PubMed ID: 31270442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
    Yamada N; Nishida Y; Tsutsumida H; Hamada T; Goto M; Higashi M; Nomoto M; Yonezawa S
    Cancer Res; 2008 Apr; 68(8):2708-16. PubMed ID: 18413738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Proteomics of the Cancer Cell Line Encyclopedia.
    Nusinow DP; Szpyt J; Ghandi M; Rose CM; McDonald ER; Kalocsay M; Jané-Valbuena J; Gelfand E; Schweppe DK; Jedrychowski M; Golji J; Porter DA; Rejtar T; Wang YK; Kryukov GV; Stegmeier F; Erickson BK; Garraway LA; Sellers WR; Gygi SP
    Cell; 2020 Jan; 180(2):387-402.e16. PubMed ID: 31978347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
    Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
    Zhen S; Li X
    Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 106.